319 related articles for article (PubMed ID: 30513304)
21. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
[TBL] [Abstract][Full Text] [Related]
22. Craniofacial mucosal immune system: importance of its unique organogenesis and function in the development of a mucosal vaccine.
Okada K; Yamasoba T; Kiyono H
Adv Otorhinolaryngol; 2011; 72():31-6. PubMed ID: 21865684
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of nasal-associated lymphoid tissue (NALT) and nasal absorption capacity in chicken.
Kang H; Yan M; Yu Q; Yang Q
PLoS One; 2013; 8(12):e84097. PubMed ID: 24391892
[TBL] [Abstract][Full Text] [Related]
24. Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasal-associated lymphoid tissue or cervical lymph nodes.
Wiley JA; Tighe MP; Harmsen AG
J Immunol; 2005 Sep; 175(5):3186-96. PubMed ID: 16116209
[TBL] [Abstract][Full Text] [Related]
25. Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine.
Hirano T; Jiao X; Chen Z; Van Waes C; Gu XX
Immunol Lett; 2006 Nov; 107(2):131-9. PubMed ID: 17030407
[TBL] [Abstract][Full Text] [Related]
26. A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration.
Sekine S; Kataoka K; Fukuyama Y; Adachi Y; Davydova J; Yamamoto M; Kobayashi R; Fujihashi K; Suzuki H; Curiel DT; Shizukuishi S; McGhee JR; Fujihashi K
J Immunol; 2008 Jun; 180(12):8126-34. PubMed ID: 18523277
[TBL] [Abstract][Full Text] [Related]
27. Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.
Mullin J; Ahmed MS; Sharma R; Upile N; Beer H; Achar P; Puksuriwong S; Ferrara F; Temperton N; McNamara P; Lambe T; Gilbert SC; Zhang Q
Vaccine; 2016 Mar; 34(14):1688-95. PubMed ID: 26902548
[TBL] [Abstract][Full Text] [Related]
28. Co-localization of lymphoid aggregates and lymphatic networks in nose- (NALT) and lacrimal duct-associated lymphoid tissue (LDALT) of mice.
Lohrberg M; Pabst R; Wilting J
BMC Immunol; 2018 Jan; 19(1):5. PubMed ID: 29368640
[TBL] [Abstract][Full Text] [Related]
29. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice.
Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H
Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512
[TBL] [Abstract][Full Text] [Related]
30. Histopathological findings of the nasopharynx-associated lymphoid tissue of pigs co-infected with porcine circovirus 2 and porcine reproductive and respiratory syndrome virus.
Toyama K; Hirai T; Sueyoshi M; Zhou Z; Niazi AM; Kawaguchi N; Fuke N; Yamaguchi R
J Vet Med Sci; 2022 Nov; 84(11):1536-1542. PubMed ID: 36223944
[TBL] [Abstract][Full Text] [Related]
31. [Lymphatic tissue of the nose (NALT) and larynx (LALT) in species comparison: human, rat, mouse].
Pabst R
Pneumologie; 2010 Jul; 64(7):445-6. PubMed ID: 20632237
[TBL] [Abstract][Full Text] [Related]
32. Imaging murine NALT following intranasal immunization with flagellin-modified circumsporozoite protein malaria vaccines.
Nacer A; Carapau D; Mitchell R; Meltzer A; Shaw A; Frevert U; Nardin EH
Mucosal Immunol; 2014 Mar; 7(2):304-14. PubMed ID: 23820750
[TBL] [Abstract][Full Text] [Related]
33. Lectin binding patterns in rat nasal-associated lymphoid tissue (NALT) and the influence of various types of lectin on particle uptake in NALT.
Takata S; Ohtani O; Watanabe Y
Arch Histol Cytol; 2000 Oct; 63(4):305-12. PubMed ID: 11073062
[TBL] [Abstract][Full Text] [Related]
34. Immune functions of nasopharyngeal lymphoid tissue.
Brandtzaeg P
Adv Otorhinolaryngol; 2011; 72():20-4. PubMed ID: 21865681
[TBL] [Abstract][Full Text] [Related]
35. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection.
Gallo O; Locatello LG; Mazzoni A; Novelli L; Annunziato F
Mucosal Immunol; 2021 Mar; 14(2):305-316. PubMed ID: 33244161
[TBL] [Abstract][Full Text] [Related]
36. Intranasal trans-sialidase-based vaccine against Trypanosoma cruzi triggers a mixed cytokine profile in the nasopharynx-associated lymphoid tissue and confers local and systemic immunogenicity.
Pacini MF; Balbi CB; Dinatale B; González FB; Prochetto E; De Hernández MA; Cribb P; Farré C; Espariz M; Blancato VS; Magni C; Marcipar I; Pérez AR
Acta Trop; 2023 May; 241():106889. PubMed ID: 36893830
[TBL] [Abstract][Full Text] [Related]
37. Nasal-associated lymphoid tissue (NALT): frequency and localization in young children.
Debertin AS; Tschernig T; Tönjes H; Kleemann WJ; Tröger HD; Pabst R
Clin Exp Immunol; 2003 Dec; 134(3):503-7. PubMed ID: 14632758
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of an M cell marker in nasopharynx- and oropharynx-associated lymphoid tissue of sheep.
Saxena VK; Diaz A; Scheerlinck JY
Vet Immunol Immunopathol; 2019 Feb; 208():1-5. PubMed ID: 30712787
[TBL] [Abstract][Full Text] [Related]
39. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue.
Wu HY; Nikolova EB; Beagley KW; Russell MW
Immunology; 1996 Aug; 88(4):493-500. PubMed ID: 8881748
[TBL] [Abstract][Full Text] [Related]
40. NALT- versus Peyer's-patch-mediated mucosal immunity.
Kiyono H; Fukuyama S
Nat Rev Immunol; 2004 Sep; 4(9):699-710. PubMed ID: 15343369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
